Tools
Stock profile

LABCORP HOLDINGS INC. (LH)

LH · Latest close $370.78 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$370.78
As of Nov 18, 2026
Tracked funds holding
4 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
4
vs previous quarter

LABCORP HOLDINGS INC. (LH) is held by 4 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 4 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $1.4M sold). 0 members of Congress reported 0 purchases vs 4 sales. Latest close $370.78 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-1.4M
Congress
0 buys vs 4 sales
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Weitz Investment Management · Ariel Investments · Jensen Investment Management — 4 tracked funds hold LH. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 4 sales ($1.4M). Insider trading 0 members of Congress reported buying (0 purchases vs 4 sales). Politician trading

Often held alongside

ORACLE CORP (ORCL) · TEXAS INSTRUMENTS INC (TXN) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · RadNet, Inc. (RDNT) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Weitz Investment Management1.92%99,050HELD Q3 filed Nov 12
Ariel Investments0.97%349,112TRIMMED (-1.4%) Q3 filed Nov 13
Jensen Investment Management0.11%16,050TRIMMED (-13.1%) Q3 filed Nov 10
Mondrian Investment Partners0.02%4,268TRIMMED (-3.3%) Q3 filed Oct 23
Maverick Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +29.7% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

372.46205.812024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding1,055 of 8,857 filers
Long-only filers among them1,054
Change vs 2026 Q1+36 net · 933 entered · 897 exited
Shares reported, all filers78,762,760
Reported value, all filers$21.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryServices-Medical Laboratories (SIC 8071)
Revenue · FY2025$14.0B
Net income · FY2025$876.5M
Total assets · FY2025$18.4B
Shares outstanding81,100,000
Market cap (at latest close)$30.1B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Aug 4, 2026.

Short interest

Shares short · Oct 15, 20262,557,656
Share of shares outstanding3.15%
Days to cover4.22

Shares short at recent settlements — Jul 31, 2026: 2.1M · Aug 14, 2026: 1.9M · Aug 31, 2026: 2.1M · Sep 15, 2026: 2.4M · Sep 30, 2026: 2.7M · Oct 15, 2026: 2.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Aug 4, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 202636
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 36.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Aug 4, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 4 sales by 4 insiders ($1.4M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 16, 2026Summy Amy B.EVP, Chief Marketing OfficerSell365$372.58$136.0KSEC filing
Nov 10, 2026Caveney Brian JEVP, Pres of BLS, CMO & CSOSell2,000$372.04$744.1KSEC filing
Nov 3, 2026Vaughn Bryan TEVP and President, DiagnosticsSell306$353.70$108.2KSEC filing
Oct 30, 2026Parham Richelle PSell1,078$361.22$389.4KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 17, 2026KERRII B ANDERSONDirector3,000$954.4KAug 17, 2026SEC filing
Aug 11, 2026Schechter Adam HOfficer, Director4,669$1.5MAug 11, 2026SEC filing
Aug 4, 2026Summy Amy B.Officer924$283.4KAug 4, 2026SEC filing
Jul 2, 2026Kyle Kathryn WOfficer92$26.3KJul 2, 2026SEC filing
Jul 2, 2026Vaughn Bryan TOfficer234$67.0KJul 2, 2026SEC filing
Jul 1, 2026van der Vaart Sandra DFormer Officer7,138$2.0MJul 1, 2026SEC filing
Jun 8, 2026Kyle Kathryn WOfficer762$201.1KJun 8, 2026SEC filing
May 11, 2026Schechter Adam HOfficer, Director5,903$1.5MMay 11, 2026SEC filing
May 6, 2026van der Vaart Sandra DFormer Officer6,238$1.6MMay 6, 2026SEC filing
Mar 27, 2026Meltzer Jonathan COfficer839$224.1KMar 27, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Apr 28, 2026Vanguard Capital ManagementSC 13G6,201,5127.5%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Apr 24, 2025BlackRock, Inc.SC 13G/A6,331,0177.6%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

0 members of Congress reported buying (0 purchases vs 4 sales).

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Delaney, April McClainHouseD04Aug 25, 2026$100,001 - $250,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Services-Medical Laboratories (SIC 8071). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Piotroski — Financial health improved over the past year

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Earnings Stability — Small earnings swings and almost no loss years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· 52-Week High — Recently printed a new 52-week high

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Piotroski — F-score: 8 · Return on assets: 4.8% · Operating cash flow: $1.6B

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.39 · Operating cash flow: $1.6B · Net income: $876.5M

· Earnings Stability — Earnings variation (CV): 0.49 · Loss years (of 10): 0 · Latest net income: $876.5M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together850.0%+1.7%+0.7%+1.1%
Heavy exit — 3+ tracked funds sold out together1100.0%+5.1%+6.2%-1.2%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold LH — ranked by lift, the co-holding pattern described in Methodology: ORACLE CORP (ORCL) · TEXAS INSTRUMENTS INC (TXN) · Natera, Inc. (NTRA) · Guardant Health, Inc. (GH) · RadNet, Inc. (RDNT) · QUEST DIAGNOSTICS INC (DGX) · EXAGEN INC. (XGN) · BillionToOne, Inc. (BLLN).

6 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 4, 20267.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Oct 28, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 21, 20267.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

ORACLE CORP (ORCL) · Track Record: how the signals scored · Practice timing on LH

One email a week: the week’s new filings and research. Subscribe free

← LGN  ·  LHX →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.